Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Takeda Pharmaceutical Co ( (JP:4502) ) has shared an update.
Takeda Pharmaceutical Company has announced the continuation of its stock compensation plans for directors and management in Japan, initially introduced in 2014 and 2016. These plans aim to align the interests of directors with shareholders by linking compensation to company performance, thereby enhancing corporate value and ensuring effective supervisory functions.
More about Takeda Pharmaceutical Co
Takeda Pharmaceutical Company Limited is a global pharmaceutical company based in Japan. It is involved in the research, development, manufacturing, and marketing of pharmaceutical products, with a focus on oncology, gastroenterology, neuroscience, and rare diseases.
Average Trading Volume: 5,242,277
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen7003.9B
Find detailed analytics on 4502 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue